Antidepressants and adverse effects in young patients: uncovering the evidence.
作者信息
Herxheimer Andrew, Mintzes Barbara
机构信息
Cochrane Collaboration, London, England.
出版信息
CMAJ. 2004 Feb 17;170(4):487-9.
Abstract
摘要
相似文献
1
Antidepressants and adverse effects in young patients: uncovering the evidence.
CMAJ. 2004 Feb 17;170(4):487-9.
2
Facing the evidence: antidepressant treatment in children and adolescents.
CMAJ. 2004 Feb 17;170(4):489-91.
3
Antidepressants and pediatric depression--the risk of doing nothing.
N Engl J Med. 2004 Oct 14;351(16):1598-601. doi: 10.1056/NEJMp048228.
4
A black-box warning for antidepressants in children?
N Engl J Med. 2004 Oct 14;351(16):1595-8. doi: 10.1056/NEJMp048279.
5
Antidepressants and suicide: rising prescription rate does not mean rising rate of new users.
BMJ. 2004 Aug 21;329(7463):461; author reply 461-2. doi: 10.1136/bmj.329.7463.461.
6
How have the SSRI antidepressants affected suicide risk?
Lancet. 2006 Jun 17;367(9527):1959-62. doi: 10.1016/S0140-6736(06)68860-0.
7
Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide?
Can J Psychiatry. 2009 Feb;54(2):69-71; discussion 76-7. doi: 10.1177/070674370905400201.
8
Fluoxetine: new indication. Depression in children: too many uncertainties.
Prescrire Int. 2008 Oct;17(97):186-7.
9
UK psychiatrists question SSRI warnings for under-18s.
CMAJ. 2004 Feb 17;170(4):455.
10
[Antidepressants and suicide].
Neuropsychopharmacol Hung. 2004 Dec;6(4):173-4.
引用本文的文献
1
Understanding Users in the 'Field' of Medications.
Pharmacy (Basel). 2016 May 6;4(2):19. doi: 10.3390/pharmacy4020019.
2
Antidepressants and Suicide Risk: A Comprehensive Overview.
Pharmaceuticals (Basel). 2010 Aug 30;3(9):2861-2883. doi: 10.3390/ph3092861.
3
Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.
Int J Obes (Lond). 2016 Nov;40(11):1742-1747. doi: 10.1038/ijo.2016.135. Epub 2016 Aug 1.
4
Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer Organization.
Front Public Health. 2015 Sep 1;3:211. doi: 10.3389/fpubh.2015.00211. eCollection 2015.
5
What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.
BMC Clin Pharmacol. 2011 Oct 25;11:16. doi: 10.1186/1472-6904-11-16.
6
Unlocking Health Canada's cache of trade secrets: mandatory disclosure of clinical trial results.
CMAJ. 2012 Feb 7;184(2):194-9. doi: 10.1503/cmaj.110721. Epub 2011 Aug 29.
7
SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.
J Can Acad Child Adolesc Psychiatry. 2011 Feb;20(1):60-7.
8
Reporting bias in medical research - a narrative review.
Trials. 2010 Apr 13;11:37. doi: 10.1186/1745-6215-11-37.
9
Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.
Drug Saf. 2009;32(11):1067-74. doi: 10.2165/11316680-000000000-00000.
10
Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
Br J Clin Pharmacol. 2007 Feb;63(2):148-56. doi: 10.1111/j.1365-2125.2006.02746.x.
本文引用的文献
1
Facing the evidence: antidepressant treatment in children and adolescents.
CMAJ. 2004 Feb 17;170(4):489-91.
2
Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.
CMAJ. 2003 Nov 25;169(11):1167-70.
3
A rating scale for depression.
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
4
Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
Am J Psychiatry. 2002 Mar;159(3):469-73. doi: 10.1176/appi.ajp.159.3.469.
5
Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.
JAMA. 2001;285(4):437-43. doi: 10.1001/jama.285.4.437.
6
Secrecy and the health protection branch.
CMAJ. 1998 Sep 8;159(5):481-3.
7
Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.
J Am Acad Child Adolesc Psychiatry. 1991 Mar;30(2):179-86. doi: 10.1097/00004583-199103000-00003.
Zotero 插件